Lazar David E. bought NBY
October 21, 2025 · Form 4 insider transaction
Lazar David E. bought 6,388,000 shares of NBY, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 100 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,388,000
Price
N/A
Total value
N/A
InsiderLazar David E.
Role—
CompanyNBY
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 21, 2025
Filing dateJanuary 29, 2026
Shares owned after6,388,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of Common Stock reported herein were issued upon the automatic conversion of the Series D Preferred Stock held by the Reporting Person three business days after the annual meeting of stockholders (the "Annual Meeting") of NovaBay Pharmaceuticals, Inc. (the "Issuer"), which occurred on October 16, 2025.